Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 36765123.
- Also identified by DOI 10.1038/s41746-023-00767-1 and PMC identifier 9918454.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Digital Health Technologies (DHTs) such as connected sensors offer particular promise for improving data collection and patient empowerment in neurology research and care. This study analyzed the recent evolution of the use of DHTs in trials registered on ClinicalTrials.gov for four chronic neurological disorders: epilepsy, multiple sclerosis, Alzheimer's, and Parkinson's disease. We document growth in the collection of both more established digital measures (e.g., motor function) and more novel digital measures (e.g., speech) over recent years, highlighting contexts of use and key trends.